Filing Details

Accession Number:
0000899243-19-028076
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-25 17:32:57
Reporting Period:
2019-11-21
Accepted Time:
2019-11-25 17:32:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
862692 Cryo Cell International Inc CCEL Services-Misc Health & Allied Services, Nec (8090) 223023093
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529249 L. Mark Portnoy 700 Brooker Creek Blvd.
St. 1800
Oldsmar FL 34677
Co-Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-11-21 77,835 $3.30 539,656 No 4 S Direct
Common Stock Disposition 2019-11-21 35,122 $3.20 504,534 No 4 S Direct
Common Stock Disposition 2019-11-21 22,020 $4.00 482,514 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 18,055 Indirect by 401K
Common Stock 71,529 Indirect by partnership
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $1.72 2011-12-01 2021-12-01 200,000 200,000 Direct
Common Stock Stock Option $2.90 2011-08-31 2021-08-31 100,000 100,000 Direct
Common Stock Stock Option $3.14 2016-04-15 2026-04-15 59,459 59,459 Direct
Common Stock Stock Option $7.92 2023-03-08 20,000 20,000 Direct
Common Stock Stock Option $7.53 2029-08-30 22,222 22,222 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-12-01 200,000 200,000 Direct
2021-08-31 100,000 100,000 Direct
2026-04-15 59,459 59,459 Direct
2023-03-08 20,000 20,000 Direct
2029-08-30 22,222 22,222 Direct
Footnotes
  1. Share of Common Stock held by Capital Asset Fund # 1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.
  2. Stock options vest 1/3 on date of grant, 1/3 on December 1, 2016 and 1/3 on December 1, 2017.
  3. Stock options will vest 1/3 on date of grant, 1/3 on December 1, 2018 and 1/3 on December 1, 2019.
  4. Stock options will vest 1/3 upon date of grant, 1/3 on December 1, 2019 and 1/3 on November 30, 2020.
  5. Shares surrendered as a result of the ratification of stock issuances and equity awards at the Company's Annual Meeting of Shareholders on November 21, 2019.